Statin use linked with lower risk of developing prostate cancer

In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer. In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.

Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.

More strictly designed clinical trial studies are needed to replicate this finding."

Kai Wang, PhD., first author from Harvard University

Journal reference:

Wang, K., et al. (2019) Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Weight-loss drug Belviq increases risk of cancer, FDA warns